221 related articles for article (PubMed ID: 21750658)
1. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
3. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression.
Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678
[TBL] [Abstract][Full Text] [Related]
4. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
5. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
Huang J; Chen J
Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
[TBL] [Abstract][Full Text] [Related]
6. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.
Alfthan K; Heiska L; Grönholm M; Renkema GH; Carpén O
J Biol Chem; 2004 Apr; 279(18):18559-66. PubMed ID: 14981079
[TBL] [Abstract][Full Text] [Related]
8. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.
Kissil JL; Johnson KC; Eckman MS; Jacks T
J Biol Chem; 2002 Mar; 277(12):10394-9. PubMed ID: 11782491
[TBL] [Abstract][Full Text] [Related]
9. p21-activated kinase links Rac/Cdc42 signaling to merlin.
Xiao GH; Beeser A; Chernoff J; Testa JR
J Biol Chem; 2002 Jan; 277(2):883-6. PubMed ID: 11719502
[TBL] [Abstract][Full Text] [Related]
10. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
[TBL] [Abstract][Full Text] [Related]
11. Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
Laulajainen M; Melikova M; Muranen T; Carpén O; Grönholm M
J Cell Mol Med; 2012 Sep; 16(9):2161-75. PubMed ID: 22325036
[TBL] [Abstract][Full Text] [Related]
12. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T; Sekido Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into NF2/Merlin tumor suppressor function.
Cooper J; Giancotti FG
FEBS Lett; 2014 Aug; 588(16):2743-52. PubMed ID: 24726726
[TBL] [Abstract][Full Text] [Related]
15. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
16. Role of Merlin/NF2 inactivation in tumor biology.
Petrilli AM; Fernández-Valle C
Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
[TBL] [Abstract][Full Text] [Related]
17. Merlin: the wizard requires protein stability to function as a tumor suppressor.
Morrow KA; Shevde LA
Biochim Biophys Acta; 2012 Dec; 1826(2):400-6. PubMed ID: 22750751
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence resonance energy transfer analysis of merlin conformational changes.
Hennigan RF; Foster LA; Chaiken MF; Mani T; Gomes MM; Herr AB; Ip W
Mol Cell Biol; 2010 Jan; 30(1):54-67. PubMed ID: 19884346
[TBL] [Abstract][Full Text] [Related]
19. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
20. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
